Adam Baker, director of science at Chr. Hansen, discussed recent in-house clinical trials observing an amplified response following administration of probiotics with HMOs, compared with pre- or probiotics given alone, at Probiota last week.
Read more about it via https://www.nutraingredients.com/News/Manufacturers/Chr.-Hansen-hints-at-future-synbiotic-production-following-significant-research-findings?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS
No comments:
Post a Comment